Safety Shot Stock (NASDAQ:JUPW)


OwnershipChart

Previous Close

$1.36

52W Range

$0.30 - $1.64

50D Avg

$1.19

200D Avg

$0.67

Market Cap

$49.33M

Avg Vol (3M)

$1.02M

Beta

0.28

Div Yield

-

JUPW Company Profile


Jupiter Wellness, Inc. develops cannabidiol (CBD) based medical therapeutics and wellness products. The company's clinical pipeline includes CaniDermRX (JW-100), a novel topical formulation containing CBD and aspartame for the treatment of eczema, dermatitis, and actinic keratosis; JW-101, a prescription product for the treatment of burns; and JW-200, a non-prescription lotion/lip balm for the treatment of symptoms of cold sores. It also manufactures, distributes, and markets a line of consumer products, such as CBD-infused sunscreen under the CaniSun brand; CBD-infused skin care lotion under the CaniSkin brand; and products for the dermatological treatments of pain and inflammation under the CaniDermRX brand. The company was formerly known as CBD Brands, Inc. Jupiter Wellness, Inc. was incorporated in 2018 and is headquartered in Jupiter, Florida.

Show More

Industry

Drug Manufacturers - Specialty & Generic

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

10

IPO Date

Oct 30, 2020

Website

JUPW Performance


Peer Comparison


TickerCompany
ANIPANI Pharmaceuticals, Inc.
PAHCPhibro Animal Health Corporation
RGCRegencell Bioscience Holdings Limited
IXHLIncannex Healthcare Limited
SSICSilver Spike Investment Corp.
CPIXCumberland Pharmaceuticals Inc.
PROCProcaps Group S.A.
PBHPrestige Consumer Healthcare Inc.
COLLCollegium Pharmaceutical, Inc.
EGRXEagle Pharmaceuticals, Inc.